Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease

被引：0
|
作者：
Gao, Xiaoya [1 ,2 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Pediat Neurol, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
来源：
FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 15卷
关键词：
Alzheimer's disease; Parkinson's disease; disease modification; neuroprotection; novel targets; neurodegeneration;
D O I：
10.3389/fnagi.2023.1247256
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Disease-modifying treatment in Parkinson's disease - opportunities and obstacles
    Bandmann, O.
    FEBS OPEN BIO, 2019, 9 : 40 - 40
  • [22] Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease
    Munoz-Torrero, D.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (24) : 2433 - 2455
  • [23] Development of disease-modifying therapies against Alzheimer's disease
    Iwatsubo, Takeshi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (09) : 491 - 494
  • [24] Challenges to the development of disease-modifying therapies in Parkinson's disease
    Schapira, A. H. V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 16 - 21
  • [25] The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
    Lauterbach, Edward C.
    Fontenelle, Leonardo F.
    Teixeira, Antonio L.
    PARKINSONS DISEASE, 2012, 2012
  • [26] Disease-modifying treatment for Alzheimer's disease: the neurotrophic approach
    Bossi, L
    ALZHEIMERS REPORTS, 1998, 1 : S29 - S30
  • [27] Huperzine A: is it an effective disease-modifying drug for Alzheimer's disease?
    Qian, Zhong Ming
    Ke, Ya
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [28] Disease-modifying Therapeutic Approaches for Alzheimer's Disease (2021)
    Froelich, Lutz
    Hausner, Lucrezia
    NERVENARZT, 2022,
  • [29] Insight Preparing for disease-modifying therapies in Alzheimer's disease
    Belder, Christopher R. S.
    Schott, Jonathan M.
    Fox, Nick C.
    LANCET NEUROLOGY, 2023, 22 (09): : 782 - 783
  • [30] Optimum Design of Disease-Modifying Trials on Alzheimer's Disease
    Xiong, Chengjie
    Luo, Jingqin
    Gao, Feng
    Chen, Ling
    Yan, Yan
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2012, 4 (03): : 216 - 227
12345